Abstract
A series of new 4-(aryl/heteroaryl-2-ylmethyl)-6-phenyl-2-[3-(4-substituted piperazine-1-yl)propyl] pyridazin-3(2H)-one derivatives were synthesized. The structures of the compounds were confirmed by IR, 1H NMR, and mass spectral data. All the compounds were evaluated for their cytotoxicity toward five human cancer cell lines of different origins viz; HeLa (Cervical), SKBR3 (Breast), HCT116 (Colon), A375 (Skin) & H1299 (Lung) at different concentrations and the IC50 values were determined. HCT116 and HeLa are the most sensitive against the compounds studied. One of them displayed moderate cytotoxicity against SKBR3. Majority of the compounds exhibited good to moderate activity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmad S, Rathish IG, Bano S, Alam M, Javed K (2010) Synthesis and biological evaluation of some novel 6-aryl-2-(p-sulfamylphenyl)-4,5-dihydropyridazin-3(2H)-ones as anti-cancer, antimicrobial, and anti-inflammatory agents. J Enz Inh Med Chem 25:266–271
Akahane A, Katayama H, Mitsunaga T (1999) Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)-pyridazinebutanoic acid (FK 838): A novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity. J Med Chem 42:779–783
Anees Siddiqui A, Mishra R, Shaharyar M (2010) Synthesis, characterization and antihypertensive activity of pyridazinone derivatives. Eur J Med Chem 45:2283–2290
Anees Siddiqui A, Mishra R, Shaharyar M, Husain A, Rashid M, Pal P (2011) Triazole incorporated pyridazinones as a new class of antihypertensive agents: design, synthesis and in vivo screening. Bioorg Med Chem Lett 21:1023–1026
Asif M, Singh D, Singh A (2011) Analgesic activity of some 6-phenyl-4-substituted benzylidene tetrahydro pyridazin-3(2H)-ones. Glo J Pharm 5:18–22
Can-Cheng G, Rong-Biao T, Ke-Lai L (2004) Chloroalkyl piperazine and nitrogen mustard porphyrins: synthesis and anticancer activity. Bioorg Med Chem 12:2469–2475
Chaudhary P, Kumar R, Verma AK, Singh D, Yadav V, Anil K, Chhillar AK, Sharma GL, Chandra R (2006) Synthesis and antimicrobial activity of N-alkyl and N-aryl piperazine derivatives. Bioorg Med Chem 14:1819–1826
Coelho A, Sotelo E, Ravina E (2003) Pyridazine derivatives, sonogashira approaches in the synthesis of 5-substituted-6-phenyl-3(2H)-pyridazinones. Tetrahedron 59:2477–2484
Demirayak S, Karaburun AC, Beis R (2004) Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities. Eur J Med Chem 39:1089–1095
Ghaffar NA, Mona KM, Mona SK, Azza MR, Galal HS, Sara NA (2011) Synthesis and anti-tumor activities of some new pyridazinones containing the 2-phenyl-1H-indolyl moiety. J Chem Pharm Res 3:248–259
Giovannoni MP, Vergelli C, Ghelardini C, Galeotti N, Bartolini A, Dal Piaz V (2003) Synthesis, characterization and antihypertensive activity of pyridazinone derivatives. J Med Chem 46:1055–1059
Gökçe M, Utku S, Küpeli E (2009) Synthesis and analgesic and anti-inflammatory activities of 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(p-substituted/nonsubstituted benzal) hydrazone derivatives. Eur J Med Chem 44:3760–3764
Livermone DGH, Bethell RC, Cammack N (1993) Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines. J Med Chem 36:3784–3794
Monge A, Parrado P, Font M, Alvarez EF (1987) Selective thromboxane synthetase inhibitors and antihypertensive agents. New derivatives of 4-hydrazino-5H-pyridazino[4,5-b]indole,4-hydrazinotriazino[4,5-a]indole, and related compounds. J Med Chem 30:1029–1035
Murty MSR, Jyotirmayi B, Krishna PR, Yadav JS (2003) Zinc mediated alkylation of cyclic secondary amines. Syn Commun 33:2483–2486
Patel RV, Kumari P, Rajani DP, Kishor HC (2011) Synthesis and studies of novel 2-(4-cyano-3-trifluoromethylphenyl amino)-4-(quinoline-4-yloxy)-6-(piperazinyl/piperidinyl)-s-triazines as potential antimicrobial, antimycobacterial and anticancer agents. Eur J Med Chem 46:4354–4365
Rubat C, Coudert P, Refouvelet B, Tronche P, Bastide P (1990) Anticonvulsant activity of 3-oxo-5-substituted benzylidene-6-methyl-(4H)-2-pyridazinylacetamides and 2-pyridazinyl acetylhydrazides. Chem Pharm Bull 38:3009–3013
Sahin MF, Badıcoglua B, Gökcea M, Küpelib E, Yesiladab E (2004) Synthesis and analgesic and anti-inflammatory activity of methyl 6-substituted-3(2H)-pyridazinone-2-ylacetate derivatives. Arch Pharm Pharm Med Chem 337:445–452
Sircar I, Weishaar RE, Kobylarz D, Moos WH, Bristol JA (1987) Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure–activity relationships and correlation with in vivo positive inotropic activity. J Med Chem 30:955–1962
Smitha VB, Vineshkumar TP, Deepti A, Nair A, Karunagaran D, Anto RJ (2005) Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-KB and the serine/threonine kinase akt and is independent of tubulin polymerization. J Bio Chem 280:6301–6308
Acknowledgments
BRR is thankful to University Grants Commission (U.G.C.). KRR and JA are thankful to the Council of Scientific & Industrial Research (CSIR), New Delhi, India for the award of fellowships.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murty, M.S.R., Rao, B.R., Ram, K.R. et al. Synthesis and preliminary evaluation activity studies of novel 4-(aryl/heteroaryl-2-ylmethyl)-6-phenyl-2-[3-(4-substituted-piperazine-1-yl)propyl]pyridazin-3(2H)-one derivatives as anticancer agents. Med Chem Res 21, 3161–3169 (2012). https://doi.org/10.1007/s00044-011-9851-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-011-9851-6